1. Unique pattern of component gene disruption in the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in serous ovarian cancer.
   Victor D Martinez et al, 2014, Biomed Res Int CrossRef
2. Potential Applications of NRF2 Modulators in Cancer Therapy
   Emiliano Panieri et al, 2020, Antioxidants CrossRef
3. Nuclear factor erythroid 2-related factor 2 modulates HER4 receptor in ovarian cancer cells to influence their sensitivity to tyrosine kinase inhibitors
   Ibrahim H. Kankia et al, 2021 CrossRef